EdiGene
- Headquarters
- Beijing
- Business Model
- B2B
- Website
- edigene.com
About
Biotech company developing genome editing technologies for drug discovery and therapeutics.
Summary
EdiGene is a Biotech company based in Beijing, China.
Similar Companies
Sana BiotechnologyIPO
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Seattle, United States201–500Biotech, Healthcare
Series D·$1.4B·Jun 2020

Abogen Biosciences
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021
Alnylam PharmaceuticalsIPO
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
ArsenalBio
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
San Francisco, United States201–500Biotech, Life Sciences
Series C·$955.0M·Sep 2024
Lyell ImmunopharmaIPO
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
South San Francisco, United States201–500Biotech, Healthcare
Venture Round·$884.0M·Jul 2025

Candid Therapeutics
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...
San Diego, United States11–50Biotech, Therapeutics
Venture Round·$875.0M·Mar 2026